Citation

Parro-Torres C, Hernandez-Huerta D, Ochoa-Mangado E, Pérez-Elías MJ, Baca-Garcia E, Madoz-Gúrpide A. AIDS Care 2022; 34(8): 1064-1072.

Copyright

(Copyright © 2022, Informa - Taylor and Francis Group)

DOI

10.1080/09540121.2021.1944598

PMID

34165358

Abstract

Mental disorders hamper immunological control of HIV infection by exerting a negative influence on antiretroviral therapy (ART) adherence. We sought to address the possible relationship between non-adherence to antiretroviral treatment (ART), mental disorders and substance use in people living with HIV/AIDS (PLWHA) in Spain, which presents a high prevalence of intravenously transmitted HIV infection. We assessed 125 PLWHA attending regular outpatient follow-up. The main adherence measure was pill collection from the Hospital Pharmacy. We included sociodemographic variables, mental disorders diagnosis, and substance use in the 12 months prior to the assessment. Harmful alcohol consumption (OR: 6.834; 95% CI: 2.008-23.257; p = 0.002), suffering from depression (OR: 5.851; 95% CI: 1.470-23.283; p = 0.012) and being at risk of suicide (OR: 3.495; 95% CI: 1.136-10.757; p = 0.029) increased the likelihood of non-adherence. 29.6% of the sample had been infected via blood contact. HCV co-infection was present in 46.4% of the study sample, increasing the likelihood of non-adherence (OR: 3.223; 95% CI: 1.119-9.286; p = 0.030). Harmful alcohol use and some serious mental disorders (especially depression and suicide risk) are consistently associated with non-adherence to ART. HCV co-infection could be an important risk marker of non-adherence among PLWHA with a high prevalence of intravenous drug use.

Language: en

Keywords

Humans; Spain; alcohol; Substance-Related Disorders; depression; mental disorder; Case-Control Studies; substance use; HIV; Alcoholism; adherence; HIV Infections; Hepatitis C; Coinfection; Anti-Retroviral Agents; Medication Adherence